Current treatment practices for anemia in patients with chronic kidney disease and future opportunities with hypoxia-inducible factor prolyl hydroxylase inhibitors: a narrative review

被引：0
|
作者：
Mercedes Kile
Patcharaporn Sudchada
机构：
[1] University of Wisconsin-Madison,School of Pharmacy
[2] Naresuan University,Faculty of Pharmaceutical Sciences
来源：
International Urology and Nephrology | 2021年 / 53卷
关键词：
Chronic kidney disease; Anemia; Iron; ESA; Hypoxia-inducible factor prolyl hydroxylase inhibitors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：283 / 290
页数：7
相关论文
共 50 条
  • [41] Whether Prolyl Hydroxylase Blocker-Roxadustat-In the Treatment of Anemia in Patients with Chronic Kidney Disease Is the Future?
    Grzeszczak, Wladyslaw
    Szczyra, Dariusz
    Snit, Miroslaw
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (04) : 1 - 16
  • [42] Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD
    Provenzano, Robert
    Besarab, Anatole
    Sun, Chao H.
    Diamond, Susan A.
    Durham, John H.
    Cangiano, Jose L.
    Aiello, Joseph R.
    Novak, James E.
    Lee, Tyson
    Leong, Robert
    Roberts, Brian K.
    Saikali, Khalil G.
    Hemmerich, Stefan
    Szczech, Lynda A.
    Yu, Kin-Hung Peony
    Neff, Thomas B.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 11 (06): : 982 - 991
  • [43] Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitors in patients with chronic kidney disease: meta-analysis of phase 3 randomized controlled trials
    Minutolo, Roberto
    Liberti, Maria Elena
    Simeon, Vittorio
    Sasso, Ferdinando C.
    Borrelli, Silvio
    De Nicola, Luca
    Garofalo, Carlo
    CLINICAL KIDNEY JOURNAL, 2024, 17 (01)
  • [44] Pleotropic effects of hypoxia-inducible factor-prolyl hydroxylase domain inhibitors: are they clinically relevant?
    Chou, Yu-Hsiang
    Pan, Szu-Yu
    Lin, Shuei-Liong
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2023, 42 (01) : 27 - 38
  • [45] Hypoxia-Inducible Factor-Proline Hydroxylase Inhibitor in the Treatment of Renal Anemia
    Hu, Xiaofan
    Xie, Jingyuan
    Chen, Nan
    KIDNEY DISEASES, 2021, 7 (01) : 1 - 9
  • [46] Hypoxia-Inducible Factor-Prolyl-Hydroxylase and Sodium-Glucose Cotransporter 2 Inhibitors for Low-Risk Myelodysplastic Syndrome-Related Anemia in Patients with Chronic Kidney Disease: A Report of Three Cases
    Yamasaki, Satoshi
    Horiuchi, Takahiko
    HEMATOLOGY REPORTS, 2023, 15 (01) : 180 - 187
  • [47] Discovery of Orally Bioavailable and Liver-Targeted Hypoxia-Inducible Factor Prolyl Hydroxylase (HIF-PHD) Inhibitors for the Treatment of Anemia
    Liu, Ping
    Wang, Liping
    DuBois, Byron G.
    Colandrea, Vincent J.
    Liu, Rongqiang
    Cai, Jiaqiang
    Du, Xiaoxing
    Quan, Weiro
    Morris, William
    Bai, Jianwu
    Bishwokarma, Bimjhana
    Cheng, Mangeng
    Piesvaux, Jennifer
    Ray, Kallol
    Alpert, Carla
    Chiu, Chi-Sung
    Zielstorff, Mark
    Metzger, Joseph M.
    Yang, Liming
    Leung, Dennis
    Alleyne, Candice
    Vincent, Stella H.
    Pucci, Vincenzo
    Li, Xiaofang
    Crespo, Alejandro
    Stickens, Dominique
    Hale, Jeffrey J.
    Ujjainwalla, Feroze
    Sinz, Christopher J.
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (12): : 1193 - 1198
  • [48] Discovery of DS-1093a: An oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of renal anemia
    Tanaka, Naoki
    Fukuda, Takeshi
    Takano, Rieko
    Sasaki, Koji
    Tsuji, Takashi
    Goto, Riki
    Kuribayashi, Takeshi
    Yamaguchi, Kyoji
    Niitsu, Yoichi
    Ishii, Ken
    Hashimoto, Masami
    Takahashi, Shinichi
    Obayashi, Hisakuni
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 111
  • [49] Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China
    Chen, Nan
    Qian, Jiaqi
    Chen, Jianghua
    Yu, Xueqing
    Mei, Changlin
    Hao, Chuanming
    Jiang, Gengru
    Lin, Hongli
    Zhang, Xinzhou
    Zuo, Li
    He, Qiang
    Fu, Ping
    Li, Xuemei
    Ni, Dalvin
    Hemmerich, Stefan
    Liu, Cameron
    Szczech, Lynda
    Besarab, Anatole
    Neff, Thomas B.
    Yu, Kin-Hung Peony
    Valone, Frank H.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 (08) : 1373 - 1386
  • [50] Efficacy of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Clinical Parameters in Patients with Heart Failure
    Yazaki, Mayu
    Nabeta, Takeru
    Takigami, Yu
    Eda, Yuko
    Fujita, Teppei
    Iida, Yuichiro
    Ikeda, Yuki
    Ishii, Shunsuke
    Ako, Junya
    MEDICINA-LITHUANIA, 2024, 60 (01):
12345